Acharya A, Yadav M, Nagpure M et al (2024) Molecular medicinal insights into scaffold hopping-based drug discovery success. Drug Discovery Today 29
Article CAS PubMed Google Scholar
Al-Worafi YM (2023) Tuberculosis management in developing countries. In: Handbook of medical and health sciences in developing countries: education, practice, and research. Springer 1–40
Ardawi MSM, Badreddine SA, Yasir M et al (2025) Overcoming beta-lactam resistance in Pseudomonas aeruginosa by targeting metallo-beta-lactamase VIM-1: a one-microsecond molecular dynamics simulation study. Front Cell Infect Microbiol 15:1521391
Article PubMed PubMed Central Google Scholar
Bagcchi S (2023) WHO’s global tuberculosis report 2022. The Lancet Microbe 4(1):e20. https://doi.org/10.1016/S2666-5247(22)00359-7
Ballinger E, Mosior J, Hartman T et al (2019) Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition. Science 363:eaau8959. https://doi.org/10.1126/science.aau8959
Bansode AS, Siddique MUM, Jain HK, Patil RB (2024) Design, synthesis and molecular dynamic studies of novel imidazo/pyrido-pyrimidine clubbed ethyl-1,2,3,4-tetrahydro-4-phenylpyrimidine-5-carboxylate derivatives as potent anti-tubercular agents. J Mol Struct 1300. https://doi.org/10.1016/j.molstruc.2023.137268
Berman HM (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242. https://doi.org/10.1093/nar/28.1.235
Article CAS PubMed PubMed Central Google Scholar
Bjerrum EJ, Palunas K, Menke J (2024) Python-based interactive RDKit molecule editing with rdEditor
Borsoi AF, Silva Ramos A, Sperotto N et al (2024) Exploring scaffold hopping for novel 2-(Quinolin-4-yloxy) acetamides with enhanced antimycobacterial activity. ACS Med Chem Lett 15:493–500
Article CAS PubMed PubMed Central Google Scholar
Bowers KJ, Chow E, Xu H et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. 84-es
Brown DG, Wobst HJ (2021) A decade of FDA-approved drugs (2010–2019): trends and future directions. J Med Chem 64:2312–2338
Article CAS PubMed Google Scholar
Chakraborty S, Chakraborty S, Sarkar B et al (2025) Scaffold hopping and de novo drug design. Computational Methods for Rational Drug Design pp 195–219
Chandrasekaran B, Abed SN, Al-Attraqchi O et al (2018) Computer-aided prediction of pharmacokinetic (ADMET) properties. In: Dosage form design parameters. Elsevier, pp 731–755
DeLano WL (2002) Pymol: An open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82–92
Dheda K, Mirzayev F, Cirillo DM et al (2024) Multidrug-Resistant Tuberculosis Nature Reviews Disease Primers 10:22. https://doi.org/10.1038/s41572-024-00504-2
Gavalda S, Faille A, Fioccola S et al (2024) Catalytic cycle of type II 4′-phosphopantetheinyl Transferases. ACS Catal 14:8561–8575
Hanwarinroj C, Thongdee P, Sukchit D et al (2022) In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions. J Mol Graph Model 115. https://doi.org/10.1016/j.jmgm.2022.108231
Article CAS PubMed Google Scholar
Hassan AM, Khateb AM, Turkistani SA et al (2024) Structural analogs of 2-(4-fluorophenyl)-6-methyl-3-(pyridin-4-yl)pyrazolo[1,5-a]pyridine for targeting Candida albicans non-essential stress kinase Yck2 through protein-ligand binding and dynamics analysis. Front Chem 12:1430157. https://doi.org/10.3389/fchem.2024.1430157
Article CAS PubMed PubMed Central Google Scholar
Jadhav S, Nair A, Mahajan P, Nema V (2024) The crosstalk between HIV-TB co-infection and associated resistance in the Indian population. Venereology 3:183–198
Jung J, Bashiri G, Johnston JM et al (2014) Crystal structure of the essential Mycobacterium tuberculosis phosphopantetheinyl transferase PptT, solved as a fusion protein with maltose binding protein. J Struct Biol 188:274–278
Article CAS PubMed Google Scholar
Kagami LP, das Neves GM, Timmers LFSM et al (2020) Geo-measures: a PyMOL plugin for protein structure ensembles analysis. Comput Biol Chem 87
Article CAS PubMed Google Scholar
Khawbung JL, Nath D, Chakraborty S (2021) Drug resistant tuberculosis: a review. Comp Immunol Microbiol Infect Dis 74. https://doi.org/10.1016/j.cimid.2020.101574
Article CAS PubMed Google Scholar
Kim M, Wainwright HC, Locketz M et al (2010) Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2:258–274. https://doi.org/10.1002/emmm.201000079
Article CAS PubMed PubMed Central Google Scholar
Kim S, Bolton EE (2024) PubChem: A large‐scale public chemical database for drug discovery. Open Access Databases and Datasets for Drug Discovery, pp 39–66
Kim S, Chen J, Cheng T et al (2025) PubChem 2025 update. Nucleic Acids Res 53:D1516–D1525
Kuang W, Zhang H, Wang X, Yang P (2022) Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis. Acta Pharmaceutica Sinica B 12:3201–3214
Article CAS PubMed PubMed Central Google Scholar
Kumar GS, Sahoo AK, Ranjan N et al (2024) Suppressing Mycobacterium tuberculosis virulence and drug resistance by targeting Eis protein through computational drug discovery. Molecular Diversity, pp 1–27
Kumari M, Waseem M, Subbarao N (2023) Discovery of multi-target mur enzymes inhibitors with anti-mycobacterial activity through a Scaffold approach. J Biomol Struct Dyn 41:2878–2899
Article CAS PubMed Google Scholar
Labbé CM, Rey J, Lagorce D et al (2015) MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43:W448–W454
Article PubMed PubMed Central Google Scholar
Leblanc C, Prudhomme T, Tabouret G et al (2012) 4′-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo. PLoS Pathog 8
Article CAS PubMed PubMed Central Google Scholar
Lee H, Kim J, Choi H (2024) Review on global burden of tuberculosis in 2022. Review on global burden of tuberculosis in 2022. Public Health Wkly Rep 17(11):438–451. https://doi.org/10.56786/PHWR.2024.17.11.2
McKinney W (2011) pandas: a foundational Python library for data analysis and statistics. Python for High Performance and Scientific Computing 14:1–9
Moglad EH (2024) Inhibiting the oligomerization of mycobacterial DNA-directed RNA polymerase (RNAP) using natural compound via in-silico techniques. Medicine in Novel Technology and Devices 21
Nguyen P, Doan P, Rimpilainen T et al (2021) Synthesis and preclinical validation of novel indole derivatives as a GPR17 agonist for glioblastoma treatment. J Med Chem 64:10908–10918. https://doi.org/10.1021/acs.jmedchem.1c00277
Article CAS PubMed PubMed Central Google Scholar
Nirwan S, Chahal V, Kakkar R (2021) Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme. J Biomol Struct Dyn 39:656–671
Article CAS PubMed Google Scholar
Ottavi S, Li K, Cacioppo JG et al (2023) Mycobacterium tuberculosis PptT inhibitors based on heterocyclic replacements of amidinoureas. ACS Med Chem Lett 14:970–976. https://doi.org/10.1021/acsmedchemlett.3c00162
Article CAS PubMed PubMed Central Google Scholar
Ottavi S, Scarry SM, Mosior J et al (2022) In vitro and in vivo inhibition of the Mycobacterium tuberculosis phosphopantetheinyl transferase PptT by amidinoureas. J Med Chem 65:1996–2022. https://doi.org/10.1021/acs.jmedchem.1c01565
Article CAS PubMed PubMed Central Google Scholar
Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. https://doi.org/10.1002/jcc.20084
Article CAS PubMed Google Scholar
PubChem Bioassay record (2009) High throughput screen to identify inhibitors of Mycobacterium tuberculosis H37Rv
Pushpakom S, Iorio F, Eyers PA et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discovery 18:41–58
Article CAS PubMed Google Scholar
Python W (2021) Python. Python releases for windows 24:
Renaud J-P (2020) Structural biology in drug discovery: methods, techniques, and practices. John Wiley & Sons
Comments (0)